Literature DB >> 30190845

Genetic epidemiology of malignant melanoma susceptibility.

Dimitrios Papakostas1, Irene Stefanaki1, Alexander Stratigos1.   

Abstract

Germline CDKN2A mutations were the first to be associated with familial melanoma. MC1R polymorphisms are associated, in conformity with epidemiological observations, with fair skin phenotype and a moderately increased risk for melanoma. The wider implementation of genome-wide association studies along with improved whole exome sequencing techniques made possible the identification of novel high-penetrant mutations (TERT, MITF, POT1, BAP1) beyond the established pathways of pigmentation and nevus count suggesting an additional role for pathways involved in cell cycle control and DNA repair. A multitude of common polymorphisms in the general population have been associated through candidate gene studies with a low risk for melanoma, supporting the hypothesis of a complex disease.

Entities:  

Keywords:  CDKN2A; GWAS; MCR1; MITF; POT1; melanoma; polymorphism; susceptibility

Year:  2015        PMID: 30190845      PMCID: PMC6094632          DOI: 10.2217/mmt.15.7

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN: 2045-0885


  25 in total

1.  A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.

Authors:  Corine Bertolotto; Fabienne Lesueur; Sandy Giuliano; Thomas Strub; Mahaut de Lichy; Karine Bille; Philippe Dessen; Benoit d'Hayer; Hamida Mohamdi; Audrey Remenieras; Eve Maubec; Arnaud de la Fouchardière; Vincent Molinié; Pierre Vabres; Stéphane Dalle; Nicolas Poulalhon; Tanguy Martin-Denavit; Luc Thomas; Pascale Andry-Benzaquen; Nicolas Dupin; Françoise Boitier; Annick Rossi; Jean-Luc Perrot; Bruno Labeille; Caroline Robert; Bernard Escudier; Olivier Caron; Laurence Brugières; Simon Saule; Betty Gardie; Sophie Gad; Stéphane Richard; Jérôme Couturier; Bin Tean Teh; Paola Ghiorzo; Lorenza Pastorino; Susana Puig; Celia Badenas; Hakan Olsson; Christian Ingvar; Etienne Rouleau; Rosette Lidereau; Philippe Bahadoran; Philippe Vielh; Eve Corda; Hélène Blanché; Diana Zelenika; Pilar Galan; François Aubin; Bertrand Bachollet; Céline Becuwe; Pascaline Berthet; Yves Jean Bignon; Valérie Bonadona; Jean-Louis Bonafe; Marie-Noëlle Bonnet-Dupeyron; Fréderic Cambazard; Jacqueline Chevrant-Breton; Isabelle Coupier; Sophie Dalac; Liliane Demange; Michel d'Incan; Catherine Dugast; Laurence Faivre; Lynda Vincent-Fétita; Marion Gauthier-Villars; Brigitte Gilbert; Florent Grange; Jean-Jacques Grob; Philippe Humbert; Nicolas Janin; Pascal Joly; Delphine Kerob; Christine Lasset; Dominique Leroux; Julien Levang; Jean-Marc Limacher; Cristina Livideanu; Michel Longy; Alain Lortholary; Dominique Stoppa-Lyonnet; Sandrine Mansard; Ludovic Mansuy; Karine Marrou; Christine Matéus; Christine Maugard; Nicolas Meyer; Catherine Nogues; Pierre Souteyrand; Laurence Venat-Bouvet; Hélène Zattara; Valérie Chaudru; Gilbert M Lenoir; Mark Lathrop; Irwin Davidson; Marie-Françoise Avril; Florence Demenais; Robert Ballotti; Brigitte Bressac-de Paillerets
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

2.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

Review 3.  Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma.

Authors:  Foteini Chatzinasiou; Christina M Lill; Katerina Kypreou; Irene Stefanaki; Vasiliki Nicolaou; George Spyrou; Evangelos Evangelou; Johannes T Roehr; Elizabeth Kodela; Andreas Katsambas; Hensin Tsao; John P A Ioannidis; Lars Bertram; Alexander J Stratigos
Journal:  J Natl Cancer Inst       Date:  2011-06-21       Impact factor: 13.506

4.  Updated field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma: the MelGene database.

Authors:  Kyriaki Antonopoulou; Irene Stefanaki; Christina M Lill; Foteini Chatzinasiou; Katerina P Kypreou; Fani Karagianni; Emmanouil Athanasiadis; George M Spyrou; John P A Ioannidis; Lars Bertram; Evangelos Evangelou; Alexander J Stratigos
Journal:  J Invest Dermatol       Date:  2014-11-19       Impact factor: 8.551

5.  The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.

Authors:  Marianne Berwick; Irene Orlow; Amanda J Hummer; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Stephen B Gruber; Hoda Anton-Culver; Roberto Zanetti; Richard P Gallagher; Terence Dwyer; Timothy R Rebbeck; Peter A Kanetsky; Klaus Busam; Lynn From; Urvi Mujumdar; Homer Wilcox; Colin B Begg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

Review 6.  Therapy for metastatic melanoma: the past, present, and future.

Authors:  Laura Finn; Svetomir N Markovic; Richard W Joseph
Journal:  BMC Med       Date:  2012-03-02       Impact factor: 8.775

Review 7.  Fifteen-year quest for microphthalmia-associated transcription factor target genes.

Authors:  Yann Cheli; Mickael Ohanna; Robert Ballotti; Corine Bertolotto
Journal:  Pigment Cell Melanoma Res       Date:  2009-11-25       Impact factor: 4.693

8.  Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma.

Authors:  V Nikolaou; X Kang; A Stratigos; H Gogas; M C Latorre; M Gabree; M Plaka; C N Njauw; K Kypreou; I Mirmigi; I Stefanaki; H Tsao
Journal:  Br J Dermatol       Date:  2011-11-02       Impact factor: 9.302

Review 9.  Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.

Authors:  Lisa M Martorano; Richard R Winkelmann; Colleen M Cebulla; Mohamed H Abdel-Rahman; Shannon M Campbell
Journal:  Int J Dermatol       Date:  2014-04-02       Impact factor: 2.736

10.  Replication and predictive value of SNPs associated with melanoma and pigmentation traits in a Southern European case-control study.

Authors:  Irene Stefanaki; Orestis A Panagiotou; Elisavet Kodela; Helen Gogas; Katerina P Kypreou; Foteini Chatzinasiou; Vasiliki Nikolaou; Michaela Plaka; Iro Kalfa; Christina Antoniou; John P A Ioannidis; Evangelos Evangelou; Alexander J Stratigos
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

View more
  1 in total

1.  Gender-specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility.

Authors:  Clara Benna; Senthilkumar Rajendran; Giovanna Spiro; Chiara Menin; Luigi Dall'Olmo; Carlo Riccardo Rossi; Simone Mocellin
Journal:  J Transl Med       Date:  2021-02-06       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.